_2020091018165303jzv.jpg "Decoding The World Of ETF")
-
My Account
My Account
BSE Live
Dec 04, 15:40Prev. Close
1047.40
Open Price
1045.00
Bid Price (Qty.)
1047.00 (25)
Offer Price (Qty.)
1049.70 (26)
NSE Live
Dec 04, 15:56Prev. Close
1047.05
Open Price
1047.05
Bid Price (Qty.)
1049.60 (17)
Offer Price (Qty.)
0.00 (0)
| Nine Months Results of Thyrocare Technologies (in Rs. Cr.) | Dec '19 | Dec '18 | Dec '17 | Dec '16 | Dec '15 | |
| Net Sales/Income from operations | 306.38 | 272.99 | 241.76 | 209.62 | 164.00 | |
| Other Operating Income | -- | -- | -- | 7.56 | 6.86 | |
| Total Income From Operations | 306.38 | 272.99 | 241.76 | 217.19 | 170.86 | |
| EXPENDITURE | ||||||
| Consumption of Raw Materials | 84.25 | 74.59 | 64.03 | 56.56 | 44.10 | |
| Purchase of Traded Goods | 1.72 | 2.33 | 1.68 | 6.24 | 4.68 | |
| Increase/Decrease in Stocks | -0.05 | -0.78 | 0.16 | -1.06 | 0.12 | |
| Power & Fuel | -- | -- | -- | -- | -- | |
| Employees Cost | 32.90 | 27.30 | 22.04 | 21.11 | 16.78 | |
| Depreciation | 14.02 | 10.52 | 8.77 | 8.56 | 8.05 | |
| Excise Duty | -- | -- | -- | -- | -- | |
| Admin. And Selling Expenses | -- | -- | -- | -- | -- | |
| R & D Expenses | -- | -- | -- | -- | -- | |
| Provisions And Contingencies | -- | -- | -- | -- | -- | |
| Exp. Capitalised | -- | -- | -- | -- | -- | |
| Other Expenses | 50.21 | 55.51 | 50.26 | 50.62 | 35.40 | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 123.33 | 103.52 | 94.83 | 75.16 | 61.72 | |
| Other Income | 8.01 | 10.61 | 12.08 | 7.94 | 3.41 | |
| P/L Before Int., Excpt. Items & Tax | 131.34 | 114.13 | 106.92 | 83.10 | 65.13 | |
| Interest | 1.05 | 0.35 | 0.29 | -- | -- | |
| P/L Before Exceptional Items & Tax | 130.29 | 113.78 | 106.63 | 83.10 | 65.13 | |
| Exceptional Items | -- | -- | -2.19 | -- | 0.30 | |
| P/L Before Tax | 130.29 | 113.78 | 104.44 | 83.10 | 65.43 | |
| Tax | 32.85 | 39.44 | 36.06 | 28.56 | 22.11 | |
| P/L After Tax from Ordinary Activities | 97.44 | 74.34 | 68.37 | 54.54 | 43.31 | |
| Prior Year Adjustments | -- | -- | -- | -- | -- | |
| Extra Ordinary Items | -- | -- | -- | -- | -- | |
| Net Profit/(Loss) For the Period | 97.44 | 74.34 | 68.37 | 54.54 | 43.31 | |
| Equity Share Capital | 52.84 | 52.80 | 53.72 | 53.72 | 53.72 | |
| Reserves Excluding Revaluation Reserves | -- | -- | -- | -- | -- | |
| Equity Dividend Rate (%) | -- | -- | -- | -- | -- | |
| EPS Before Extra Ordinary | ||||||
| Basic EPS | 18.42 | 13.91 | 12.77 | 10.15 | -- | |
| Diluted EPS | 18.38 | 13.88 | 12.73 | 10.14 | -- | |
| EPS After Extra Ordinary | ||||||
| Basic EPS. | 18.42 | 13.91 | 12.77 | 10.15 | -- | |
| Diluted EPS. | 18.38 | 13.88 | 12.73 | 10.14 | -- | |
| Public Share Holding | ||||||
| No Of Shares (Crores) | -- | -- | -- | -- | -- | |
| Share Holding (%) | -- | -- | -- | -- | -- | |
| Promoters and Promoter Group Shareholding | ||||||
| a) Pledged/Encumbered | ||||||
| - Number of shares (Crores) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- | |
| b) Non-encumbered | ||||||
| - Number of shares (Crores) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- |
02.11.2020
Thyrocare Techn Standalone September 2020 Net Sales at Rs 148.54 crore, up 37.68% Y-o-Y
30.10.2020
Thyrocare Techn Standalone September 2020 Net Sales at Rs 148.54 crore, up 37.68% Y-o-Y
08.08.2020
Sell Thyrocare Technologies; target of Rs 307: Prabhudas Lilladher
03.08.2020
Thyrocare Techn Standalone June 2020 Net Sales at Rs 54.40 crore, down 45.87% Y-o-Y
02.11.2020
Thyrocare Techn Standalone September 2020 Net Sales at Rs 148.54 crore, up 37.68% Y-o-Y
30.10.2020
Thyrocare Techn Standalone September 2020 Net Sales at Rs 148.54 crore, up 37.68% Y-o-Y
03.08.2020
Thyrocare Techn Standalone June 2020 Net Sales at Rs 54.40 crore, down 45.87% Y-o-Y
28.05.2020
Thyrocare Techn Standalone March 2020 Net Sales at Rs 93.62 crore, down 3.77% Y-o-Y
